261 related articles for article (PubMed ID: 35967385)
1. The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis.
Duarte-Silva E; Ulrich H; Oliveira-Giacomelli Á; Hartung HP; Meuth SG; Peixoto CA
Front Immunol; 2022; 13():946698. PubMed ID: 35967385
[TBL] [Abstract][Full Text] [Related]
2. The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
Safarzadeh E; Jadidi-Niaragh F; Motallebnezhad M; Yousefi M
Inflamm Res; 2016 Jul; 65(7):511-20. PubMed ID: 26960979
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID.
Sauer AV; Brigida I; Carriglio N; Hernandez RJ; Scaramuzza S; Clavenna D; Sanvito F; Poliani PL; Gagliani N; Carlucci F; Tabucchi A; Roncarolo MG; Traggiai E; Villa A; Aiuti A
Blood; 2012 Feb; 119(6):1428-39. PubMed ID: 22184407
[TBL] [Abstract][Full Text] [Related]
4. The role of adenosinergic pathway in human autoimmune diseases.
Dong K; Gao ZW; Zhang HZ
Immunol Res; 2016 Dec; 64(5-6):1133-1141. PubMed ID: 27665459
[TBL] [Abstract][Full Text] [Related]
5. A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance.
Robin E; Marcillac F; Raddatz E
Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(7):R614-26. PubMed ID: 25632022
[TBL] [Abstract][Full Text] [Related]
6. The adenosinergic system: a potential player in the pathogenesis of ANCA-associated vasculitis?
Kling L; Krämer BK; Yard BA; Kälsch AI
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):143-151. PubMed ID: 29745882
[TBL] [Abstract][Full Text] [Related]
7. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency.
Hershfield MS
Eur J Immunol; 2005 Jan; 35(1):25-30. PubMed ID: 15580654
[TBL] [Abstract][Full Text] [Related]
8. Adenosinergic signaling as a target for natural killer cell immunotherapy.
Wang J; Matosevic S
J Mol Med (Berl); 2018 Sep; 96(9):903-913. PubMed ID: 30069747
[TBL] [Abstract][Full Text] [Related]
9. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract][Full Text] [Related]
10. The role of the adenosinergic system in lung fibrosis.
Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory activity of adenosine and its role in human cancer progression.
Muller-Haegele S; Muller L; Whiteside TL
Expert Rev Clin Immunol; 2014 Jul; 10(7):897-914. PubMed ID: 24871693
[TBL] [Abstract][Full Text] [Related]
12. Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.
Mandapathil M; Hilldorfer B; Szczepanski MJ; Czystowska M; Szajnik M; Ren J; Lang S; Jackson EK; Gorelik E; Whiteside TL
J Biol Chem; 2010 Mar; 285(10):7176-86. PubMed ID: 19858205
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of Adenosinergic Signaling in Systemic and Organ-Specific Autoimmunity.
Vuerich M; Harshe RP; Robson SC; Longhi MS
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691212
[TBL] [Abstract][Full Text] [Related]
14. ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis.
da Silva JLG; Passos DF; Bernardes VM; Leal DBR
Immunol Lett; 2019 Oct; 214():55-64. PubMed ID: 31479688
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
[TBL] [Abstract][Full Text] [Related]
16. Critical Role for the Adenosine Pathway in Controlling Simian Immunodeficiency Virus-Related Immune Activation and Inflammation in Gut Mucosal Tissues.
He T; Brocca-Cofano E; Gillespie DG; Xu C; Stock JL; Ma D; Policicchio BB; Raehtz KD; Rinaldo CR; Apetrei C; Jackson EK; Macatangay BJ; Pandrea I
J Virol; 2015 Sep; 89(18):9616-30. PubMed ID: 26178986
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Purine Metabolism-Potential Target in Multiple Sclerosis.
Laketa D; Lavrnja I
Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38499905
[TBL] [Abstract][Full Text] [Related]
18. Adenosine signaling: Next checkpoint for gastric cancer immunotherapy?
Shi L; Yang L; Wu Z; Xu W; Song J; Guan W
Int Immunopharmacol; 2018 Oct; 63():58-65. PubMed ID: 30075429
[TBL] [Abstract][Full Text] [Related]
19. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
